“I’ve worked with the RNA team for over a decade across my current and previous companies. They are our go to valuation firm for valuation because they know the industry, are responsive and understand the nuances that drive transactions just as much as accounting.”
“We started working with the RNA team when we realized that the large branded firm that we were working with needed too much hand holding to understand our investments and the royalty industry. We switched to RNA because they understand the sector, are responsive and efficient, and are in the flow of the biopharma ecosystem.”
“The RNA team has helped us with tax and financial reporting-oriented valuation work. Its nice to work with a firm that not only understands the intricacies of reporting requirements but actually understands the drug development business.”
“The RNA team is responsive and efficient and understands the nuances of valuation as pertains to our sector, and we valued our partnership with them.”
RNA Advisors, LLC, a leading valuation and strategic... [read more]
Since 2015, RNA Advisors has provided valuation, transactional... [read more]
By Jeff Williamson THE SITUATION: A healthcare company... [read more]
By Jeff Suchocki, CFA The Situation: Adoption of... [read more]
By Jeff Williamson THE SITUATION: A medical device... [read more]
THE PROBLEM: A healthcare technology company that sells... [read more]
Jeff Williamson has joined the RNA Advisors growing... [read more]
THE PROBLEM: A publicly traded clinical stage biotech... [read more]
Enter your email address below to receive updates from RNA Advisors.
